* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Pathogenic Mechanisms
Survey
Document related concepts
Urinary tract infection wikipedia , lookup
Trimeric autotransporter adhesin wikipedia , lookup
Bacterial cell structure wikipedia , lookup
Lyme disease microbiology wikipedia , lookup
Neonatal infection wikipedia , lookup
Hospital-acquired infection wikipedia , lookup
Schistosomiasis wikipedia , lookup
Cross-species transmission wikipedia , lookup
Bacterial morphological plasticity wikipedia , lookup
Globalization and disease wikipedia , lookup
Sociality and disease transmission wikipedia , lookup
Molecular mimicry wikipedia , lookup
Germ theory of disease wikipedia , lookup
Infection control wikipedia , lookup
Transmission (medicine) wikipedia , lookup
Transcript
Pathogenic Mechanisms • Hugh B. Fackrell • Filename: PathMech.ppt 1 4/30/201 Outline • • • • • • 2 Infection vs Disease Pathogenicity Virulence Pathogenic factors Latency Dormancy Communicability 4/30/201 Saprophyte • nutrient source is non-living • can become parasite 3 4/30/201 Parasitism • host/microorganism interaction • Mutualism - both host and parasite benefit. • Commensalism - the parasite does no damage to the host. • Pathogen - the parasite damages the host. • Opportunism - the parasite takes advantage of the weakened condition of the host. 4 4/30/201 Microbial Infection vs Disease • Infection: colonization of the body with microbe – usually non pathogenic – indigenous or commensal – beneficial • Disease: breach of host defenses – microbes infect tissues not normally exposed 5 4/30/201 Infection: Benefits • Metabolites – E. coli makes vitamin K • Bacterial antagonism – E.coli blocks colonization of gut by S. aureus – evidence: antibiotic sterilization before abdominal surgery – subsequent Staphylococcal infections – enteritis • Encourage immune system – axenic animals have poor immunity 6 4/30/201 Infection: Adverse Effects • Staphylococcal infection – Produces penicillinase – Concurrent infection of Neisseria gonorrhaeae – Becomes disease gonorrhea 7 4/30/201 Microbial Disease • Microbial disease is the exception – imbalance favours the microbe • 3% of all microbes pathogenic – majority of known microbes • >95% do not cause disease – virtually unknown 8 4/30/201 Location of Microbe in Host • Location often decides outcome of Infection vs disease • Streptococcus – Infection: nasopharynx – Disease: heart – bacterimiae after tooth extraction • E. coli – Infection gut – Disease: cystitis in urinary tract 9 4/30/201 Contagious Transmission • can be transmitted from one host to another (communicable) • some infections acquired from indigenous flora are categorized as communicable. 10 4/30/201 Communicability • Communicable: spread directly or indirectly from one host to another – chickenpox, measles, tuberculosis, typhoid fever • Contagious: easily communicable – eg chickenpox,measles, sore throat • Non communicable: Not spread from host to host – tetanus 11 4/30/201 Dormancy • Latency = Dormancy: causative microbe remains inactive in the host for some time but later becomes active to produce the signs and symptoms of the disease 12 4/30/201 Carrier State • Individual infected – results from a previous disease state (may be temporary) – the host is a true carrier • microbe in balance with that individual • No overt signs or symptoms • reservoir for infection of others –Typhoid Mary 13 4/30/201 Koch’s Postulates • The organism should be found in all cases of the disease and its distribution in the body should be in accordance with the lesions observed. • The organism should be cultivated outside the body of the host, in pure culture, for several generations of the pathogen. • The disease should be reproduced in susceptible animals. 14 4/30/201 Etiology Science of the causes of disease • • • • the nature of the host - species the condition of the host the nature of the disease agent the transmission of the agent 15 4/30/201 Etiology of Disease (1/2) • Specimen from patient containing infectious agent cultured. • Pure culture obtained and described; identified if possible. • Inoculation and observation of test animal. • Many organs removed and cultured. 16 4/30/201 Etiology of Disease (2/2) • Isolation and identification of the test organism. • Inoculation of a second test animal. • Culture of second test animal. • Antibodies in blood of human or animal. • Immunity developed to the infecting agent in recently recovered animal. • Animal protected by vaccine or toxoid. 17 4/30/201 Pathogenicity • Ability or potential to cause disease attributed to a genus or species • Dependent on ability to – enter the host – adapt and multiply in the host – exit from the host – transmit to new host 18 Keppie Smith 4/30/201 Portal of Entry • • • • May multiply at entry site> lesion Often enters multiplies elsewhere 2/3 Respiratory 1/3 intestine, urethra, conjunctiva and skin 19 4/30/201 Multiplication in Host • Rate of multiplication different in vivo and in vitro • time to overt symptoms • Carrier state • reservoir gall bladder • Temperature – viruses – aspirin 20 4/30/201 Exit from Host • Usually by same route a entry 21 4/30/201 Bacterial transmission • Droplets • Fomites • Direct contact – sexual – non sexual • Bites – insects – animals 22 4/30/201 Types of Pathogens • pathogens characterized as “frank” Salmonella • opportunistic pathogens - E. coli in urinary tract • non-pathogens - such as Serratia marcescens may become infectious agents 23 4/30/201 Virulence • DEGREE of pathogenicity shown by a specific strain of an organism – C. diptheriae > diptheria • variables include: – – – – – 24 number of infecting bacteria route of entry into body specific host defense mechanisms non-specific host defense mechanisms virulence factors of the bacterium 4/30/201 Virulence Measurement • Measures the pathogenicity of a isolate – variable among strains • Measure of Virulence – Median Dose – Minimum Effective Dose 25 4/30/201 Median Dose Amount that affects half the population Pathogen 26 4/30/201 Cause of Virulence Variation • Dose of pathogen • Virulence/Pathogenic factors 27 4/30/201 Dose of Pathogen • Typhoid Fever – S. typhosa contaminated water – 1-100 bacteria no effect • Boils – – – – 28 Staphylococcus aureus just on surface 7 x 10 6cells on suture or scratch ~1000 cells “stictch abcesses” 4/30/201 “Pathogenic Factors” • Gene mutation – S. pneumoniae- capsule – Shigella > dysentery • Lysogeny – scarlet fever – diptheria • Capsules – Klebsiella > polysaccharide – Anthrax > protein capsule 29 4/30/201 “Pathogenic Factors” • Inhibit host metabolism – M. tuberculosis > tuberculosis – mycolic acid blocks lysosomal enzymes • Resist host metabolism – – – – 30 stomach acids bile salts enzymes salt 4/30/201 Invasion Factors • usually surface components • also enzymes - proteases • tissue lysins Adherence factors • pili (fimbriae) • fibronectin receptors Capsules • prevent phagocytosis • opsonization 31 4/30/201 Adhesion to Host Allows Microbe : more stable foothold at the portal of entry • bind to host cells • penetrate the epithelial boundary • become established in the tissues 32 4/30/201 Adhesion Mechanisms • Fimbriae on bacterial cells • Adherent capsules, slime layers or other sticky substances • Viral envelope spikes • Pathogen hooks on filaments of target cells 33 4/30/201 Adhesins • Afimbrial adhesins are proteins that assist in binding bacteria to the host cell. • F Protein:Streptococcus pyogenes – assists binding to fibronectin,a protein on host cell surface. • M Protein • Lipoteichoic acid 34 4/30/201 Biofilm • - multilayer bacterial populations embedded in a polysaccharide matrix that is attached to same surface. 35 4/30/201 Siderophores • Iron acquisition : Fe low in human and is bound to lactoferrin transferrin ferritin hemin Bacteria compete for Fe using Siderophores: Low molecular weight compounds that chelate iron Ex. Enterochelin Fe+++ 36 4/30/201 Siderophore Competes for Fe3+ Sideriophore Lactorferrin Fe3+ Siderophore Receceptor 37 Transferrin 4/30/201 Toxigenicity • Production and release of an extracellular microbial product that disrupts the host’s normal physiology • Proteins > exotoxins • Function away from bacterium • Potent poisons – diptheria toxin – tetanus toxin – botulism toxin 38 4/30/201 Exotoxins vs Endotoxins Exotoxins Endotoxins • • • • • • • • • • • • • • • • • • usually Gram +ve extracellular released from live cell protein MW 15,000 -100,000 Heat labile toxoid Antigenic > vaccine extremely potent 39 from Gram -ve part of cell wall released from dead cell lipopolysaccharide MW millions heat stable no toxoid poorly antigenic less potent 4/30/201 Toxins: Biological Functions • • • • Exotoxins Cytotoxic Neurotoxic Enterotoxic – enteron = gut 40 • Endotoxins • cause fever • changes in blood pressure • inflammation • lethal shock 4/30/201 Infection Process • an infection develops into disease when the balance between microbial pathogenicity and host resistance is tipped toward the agent. Infectious Agent Host (human, animal, plant) Infection Established Infection Rejected = no disease Host Physiology Protects Infection Moderate = subclinical disease Infectious Agent Successful 41 Infection Established = disease 4/30/201 Host Susceptibility • Humoral Defense Mechanisms • Cellular Defense Mechanisms • Inflammation - a combination of humoral and cellular 42 4/30/201 Resistance to Bacterial Infections – Phagocytosis – Immune response – Non-specific mechanisms 2. Bacteria – multiply – objective not to destroy the host 3. Host - Mediated Pathogenesis – for example, tuberculosis - tissue damage results from toxic mediators released by lymphoid cells. 43 4/30/201 Non-Specific Physiological Host Defense Mechanisms • Innate or Natural Immunity • an individual is born with certain mechanisms of resistance to infectious agents • also called racial or inherent immunity. 44 4/30/201 Mechanisms of Microbial Antagonism • attachment site occupied with indigenous flora (commensals); usually bacteria • bacteriocins - proteins secreted by the indigenous flora that inhibit the growth of other bacteria • competitive deletion of essential nutrients • production of toxic by-products – genitourinary tract - at menarche, tissues of vagina and cervix become populated with Lactobacilli which lower the pH to 4.4-4.6; inhibitory to gram negative enterics. 45 4/30/201 Physical Barriers & Chemical Agents • • • • • • • • • Intact Skin: acid pH epithelial surface Staphylococcus aureus (pathogen); also carried as indigenous flora Mucous membranes: vagina bowel respiratory tract more easily penetrated than the intact skin 4/30/201 46 Mucous: • motion of cilia • coughing/sneezing 47 4/30/201 Physical Barriers & Chemical Agents • • • • • Eyes: flushing action lysozyme Outer ear canal: wax 48 4/30/201 Alimentary canal • • • • saliva (antibodies) some protection from stomach acid (over rated) indigenous flora diarrhea 49 4/30/201 Genitourinary • urine flushes out pathogens • vaginal pH prevents some bacteria from growing 50 4/30/201 Physical Barriers • Phagocytic cells: – Ingests and destroys pathogens • Ciliated cells: – sweep pathogens away from other cells 51 4/30/201 Chemical Agents Lysozyme: • dissolves peptidoglycan Fatty acids: • prevents bacterial growth • sebaceous glands Complement: • Mediates phagocytosis Perspiration: • lactic acid lowers pH 52 4/30/201 Mucosal Surfaces - Chemical Agents • Lysozyme • breaks the N-acetylmuraminic acid and Nacetyl glucosamine link in gram positive bacteria (i.e. tears) • Lactoferrin • iron binding protein competes with microbes for iron • Lactoperoxidase • milk and saliva •53Secretory IgA 4/30/201 Mucosal Surfaces - Chemical Agents • pH and Peristalsis in Gastrointestinal System • pH of the stomach during digestion drops to 2-4 • Peristalsis - intestine • Respiratory Mucosa – particles greater than 5 µm are moved by cilia – particles smaller than 5 µm are phagocytized by alveolar macrophages • Urinary Tract – acidic pH has a flushing action 54 4/30/201 Bacteria as Disease Agents • Depend on • the structure and function of the organism i.e. How metabolism and growth characteristics relate to the disease state and diagnosis • host defense mechanisms and host/ parasite interactions • mechanism of pathogenicity – toxins – invasive factors 55 4/30/201 Diagnosis of Bacterial Disease • Clinical - signs and symptoms, history, exposure, epidemiology • Laboratory - specimens sent to laboratory Both not always necessary but preferable 56 4/30/201 Bacterial Defense Mechanisms • Cell Envelope – Capsule – Peptidoglycan – Cytoplasmic membrane 57 4/30/201 Capsules – usually seen only in direct smear of clinical material – prevents phagocytosis 58 4/30/201 Peptidoglycan – – – – 59 simulates endogenous pyrogen osmotic regulation leucocyte chemoattractant anticomplementary 4/30/201 Cytoplasmic Membrane – osmotic barrier – regulates transport 60 4/30/201 Growth Patterns of Bacterial Pathogens • Obligate intracellular pathogens • Faculative intracelular pathogens • extracellular pathogens 61 4/30/201 Obligate Intracellular Bacterial Pathogens • Rickettsia spp • Coxiella burnetii • Chlamydia spp 62 4/30/201 Facultative Intracellular Bacterial Pathogens Salmonella spp Shigella spp Legionella pneumophila Invasive Escherichia coli Neisseria spp Mycobacterium spp Bordetella pertussis 63 4/30/201 Predominantly Extracellular Bacterial Pathogens Mycoplasma spp Pseudomonas aeruginosa Enterotoxigenic Escherichia coli Vibrio cholerae Staphylococcus aureus Streptococcus pyogenes Haemophilus influenzae Bacillus anthracis 64 4/30/201